Milgrey Finance board meet shifted: Q1FY27 on Aug 13

Key update: board meeting moved by two days

Milgrey Finance & Investments Ltd has postponed its board meeting that was earlier scheduled for August 11, 2026. The meeting has been adjourned and rescheduled to August 13, 2026. The company is expected to take up the approval of its unaudited financial results for Q1FY27 (quarter ended June 30, 2026) at the rescheduled session. The disclosure is tied to Regulation 29 of the SEBI (LODR) Regulations, which governs prior intimation for board meetings where financial results are considered. For shareholders tracking near-term disclosures, the immediate impact is a two-day shift in the expected results date.

What the August 13 board meeting will consider

The central agenda item highlighted is the approval of un-audited financial results for Q1FY27 ended June 30, 2026. Since the meeting date has moved, the results approval is also now expected on August 13 rather than August 11. The information available does not indicate any change in the subsequent filing process with stock exchanges after board approval. Typically, companies file results shortly after the board signs off, and the update suggests no additional lag beyond the rescheduling. For market participants, this means the information timeline is extended by two days, but the overall compliance sequence remains intact based on what has been stated.

Revised schedule at a glance

The rescheduling is straightforward and limited to the board meeting date. The announcement date for the quarterly results, referenced as August 11, 2026 in the company’s calendar, now effectively shifts to August 13, 2026 due to the adjournment.

What shareholders should note about the delay

Shareholders should factor in that the release of Q1FY27 financial results is delayed by two days. The company’s update explicitly points to approval on August 13, 2026 instead of August 11, 2026. There is also a clear statement that there is no indication of any delay in filing the results with the stock exchanges after approval. In practical terms, this means investors waiting for quarter-end performance numbers will receive them later than earlier expected, but the post-board compliance flow is not flagged as disrupted.

Stock snapshot and market-cap figures cited

The stock data cited shows Milgrey Finance & Investments trading at ₹48.85, up ₹4.11 (9.19%), with a timestamp of BSE: 10 Aug, 04:01 PM. The market capitalisation is also cited as ₹105.22900625 crore, calculated based on the latest share price. Separately, another market snapshot in the provided information mentions a market capitalisation of around ₹134 crore, alongside commentary on a monthly recovery of 23.6% and an annual decline of approximately 33.5%. These figures appear in the same information set and should be read as values presented at different times or from different snapshots.

Fundraising context: rights issue up to ₹60 crore

Milgrey Finance & Investments Ltd has approved raising up to ₹60.00 crore through a rights issue of equity shares with a face value of ₹10.00 each. The approval is referenced with dates including June 29, 2026, with descriptions such as “to raise up to 600 million rupees via rights issue”, which is consistent with ₹60 crore (since ₹600 million equals ₹60 crore). The rights issue context matters because it can influence how investors interpret near-term corporate actions alongside quarterly results. However, the current update is specifically about the board meeting rescheduling and the timing of Q1FY27 results approval.

Business profile and listing details

Milgrey Finance & Investments Ltd (BSE: 511018) was established in 1983 and is described as an India-based non-banking financial company. Its stated focus is investment activities, including financing film producers and investing in shares and securities on both short-term and long-term bases. The ticker symbol mentioned is ZMILGFIN, and the information set also includes a “Last updated: 2026-06-26 14:53 IST” marker for one of the company profile references.

Recent board decisions: authorised capital proposal declined

Apart from the results calendar, the information also notes that the company’s board met on June 24, 2026, and declined a proposal to increase authorised share capital and alter the Memorandum of Association. This provides additional context on corporate actions considered in the recent period, alongside the later rights issue approval referenced on June 29, 2026. These items, taken together, show that capital structure and fundraising considerations have been active board topics in FY26.

Financial performance context from recent quarters

The quarterly data provided (in ₹ crore) shows operating revenue at 0 across multiple quarters, while other income and expenses drive profitability swings. Other income is listed as ₹0.24 crore (Dec 2024), ₹0.90 crore (Jun 2025), ₹0.74 crore (Sep 2025), ₹0.00 crore (Dec 2025), and -₹2.48 crore (Mar 2026). Net profit is shown as ₹0.22 crore (Dec 2024), ₹0.64 crore (Jun 2025), ₹0.39 crore (Sep 2025), ₹0.00 crore (Dec 2025), and -₹2.32 crore (Mar 2026). A separate note also states that Q4 FY26 results declared on May 27, 2026 reported a net loss of ₹2.32 crore for the quarter ended March 31, 2026.

Ownership snapshots mentioned

The shareholding snapshots included show promoter holding at 19.47% (Dec 2024, Mar 2025, Jun 2025), falling to 13.72% (Sep 2025) and 1.54% (Dec 2025). Another table lists “investors” at 80.53% (Mar 2025), 86.28% (Sep 2025), 98.46% (Dec 2025), and 100.00% (Mar 2026 and Jun 2026). It also names an entity, “adon financial holdings l...”, at 1.15% in Jun 2026. These percentages are presented as part of the available data and provide a backdrop for shareholders tracking changes over time.

Key figures table (as cited)

The following table compiles the core event and a few market and corporate action figures exactly as referenced.

Why this matters for investors tracking disclosures

A board meeting date change is often a narrow procedural update, but it matters because it moves the timing of price-sensitive financial results. For Milgrey Finance & Investments, the direct outcome is a two-day delay in Q1FY27 results approval. Given that recent quarters show profitability largely influenced by other income and expenses rather than operating revenue, the quarterly release can still be an important data point for investors assessing consistency and drivers of earnings. The added context of a rights issue approval up to ₹60 crore also increases attention on near-term disclosures and balance sheet positioning, even though the current announcement is limited to the meeting schedule.

Closing note

Milgrey Finance & Investments has shifted its board meeting to August 13, 2026, and Q1FY27 unaudited results are now expected to be approved on that date. The company’s update indicates no specific delay in filing with exchanges after approval, suggesting the rest of the reporting process should proceed as usual once the board meets.